Google life sciences team and Sanofi announced that they are collaborating to improve care and outcomes for people with type 1 and type 2 diabetes.
They will work together on new digital technology and tools to Improve Diabetes Health outcomes.
It aims to use data and miniaturized technology to provide patients with more tools to self-manage their disease, healthcare professionals with the ability to better support and treat patients.
The collaboration will pair Sanofi’s leadership in diabetes treatments and devices with Google’s expertise in analytics, miniaturized electronics and low power chip design.
The companies will explore how to improve diabetes care by developing new tools that bring together many of the previously siloed pieces of diabetes management and enable new kinds of interventions. This includes health indicators such as blood glucose and hemoglobin A1c levels, patient-reported information, medication regimens and sensor devices.
Olivier Brandicourt, MD, Chief Executive Officer, Sanofi said, “As a global leader in diabetes care, we have both an obligation and a commitment to provide integrated solutions for people living with diabetes. This initiative combines Sanofi’s strength and knowledge in diabetes with Google’s leadership in technology and analytics to create a first-of-its-kind initiative with the potential to transform diabetes care.”
Andy Conrad, CEO of the life sciences team at Google, said, “With new technologies emerging to provide a more continuous and real-time view of a patient’s health, we can see the promise for more proactive and effective ways to control diabetes. Together with Sanofi, we believe diabetes management can be simpler and more convenient, which may help patients achieve an improved quality of life.”
“We have built expertise in providing holistic, integrated solutions that combine medicines, devices, technologies and services,” said Pascale Witz, Executive Vice President, Sanofi, who will lead the Global Diabetes and Cardiovascular Care Business Unit in the company’s new organizational structure. “The life sciences team at Google can help us improve the patient experience, outcomes and manage healthcare costs more effectively.”
“We are experiencing a worldwide pandemic of diabetes, and it’s very encouraging to see healthcare and technology innovators step up to the challenge of providing cutting edge tools and care advancing technologies to help people with diabetes manage their disease, 24/7,” said John L. Brooks, III, President and CEO of Joslin Diabetes Center, which is a partner to the collaboration.
“Technology, sensors, analytics, and digital solutions will revolutionize how blood sugars are managed, which will deliver improved quality of life, lowering the risk of complications and reducing the costs and barriers associated with diabetes care. Ultimately, I truly hope we’re able to turn the Joslin Diabetes Center into a museum.”
